PMC:7784830 / 8395-8450 JSONTXT

{"target":"https://pubannotation.org/docs/sourcedb/PMC/sourceid/7784830","sourcedb":"PMC","sourceid":"7784830","source_url":"https://www.ncbi.nlm.nih.gov/pmc/7784830","text":"Tocilizumab – Roche initiated phase III clinical trials","tracks":[{"project":"LitCovid-PubTator","denotations":[{"id":"173","span":{"begin":0,"end":11},"obj":"Chemical"}],"attributes":[{"id":"A173","pred":"tao:has_database_id","subj":"173","obj":"MESH:C502936"},{"subj":"173","pred":"source","obj":"LitCovid-PubTator"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}]}],"config":{"attribute types":[{"pred":"source","value type":"selection","values":[{"id":"LitCovid-PubTator","color":"#ecd793","default":true}]}]}}